Excluded were any patients with sensitivity to amlodipine, valsartan, or other CCBs or ARBs; patients taking any investigational agent in the last 30 days; and those prescribed other CCBs or ARBs ...
In another such trial (VALUE), researchers randomized 15,245 hypertensive patients (minimum age, 50; mean BP, 155/87 mm Hg) in 31 countries to receive the angiotensin-receptor blocker valsartan or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback